[1] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)
[J].中国糖尿病杂志,2012,20(1):81-117.
[2] Hammond RW, Schwartz AH, Campbell MJ,et al. Collab?
orative drug therapy management by pharmaci-sts[J].Phar?
macotherapy,2003,23(9):1210-1225.
[3] Kauffman Y, Jonkman L, Lupu A. Exploring the value of clin?
ical pharmacy services for patients with diabetes in safety net
settings[J].Research in Social and Administrative Pharma?
cy,2013,9(6):770-776.
[4] Smith M. Pharmacists’Role in Improving Diabetes Medica?
tion Management[J].Journal of Diabetes Science and Tech?
nology,2009,3(1):175-178.
[5] Eades CE, Ferguson JS, O'Carroll RE. Public health in com?
munity pharmacy: a systematic review of pharmacist and con?
sumerviews[J].BMC Public Health,2011,(11):582.
[6]高蕾莉,纪立农,陆菊明,等.2009~2012年我国2型糖尿病患者
药物治疗与血糖控制状况调查[J].中国糖尿病杂志,2014,22
(7):594-598.
[7]陆菊明,纪立农,郭晓蕙,等.中国2型糖尿病患者人胰岛素治
疗状况调查的研究[J].中国糖尿病杂志,2013,21(9):803-806.
[8]杨敏,柳洁.中国糖尿病防治现状[J].中国医学创新,2014,11
(7):149-151.
[9]O'Connor PJ, Schmittdiel JA, Pathak RD,et al. Randomized
trial of telephone outreach to improve medication adherence
and metabolic control in adults with diabetes[J].Diabetes
Care,2014,37(12):3317-3324.
[10]McCord AD. Clinical impact of a pharmacist-managed diabe?
tes mellitus drug therapy management service[J].Pharmaco?
therapy,2006,26(2):248-253.
[11]Horning KK, Hoehns JD, Doucette WR. Adherence to clinical
practice guidelines for7chronic conditions in long-term-care
patients who received pharmacist disease management services
versus traditional drug regimen review[J].J Manag Care
Pharm,2007,13(1):28-36.
[12]Follin SL, Hansen LB. Current approaches to the prevention
and treatment of postmenopausal osteoporosis [J].Am J
Health SystPharm,2003,60(9):883-901.
[13]Lipton HL, Bird JA. The impact of clinical pharmacists' con?
sultations on geriatric patients' compliance and medical care
use:a randomized controlled trial[J].Gerontologist,1994,34
(3):307-15.
[14]Krass I, Armour CL, Mitchell B,et al. Clinical practice As?
sessment of a community pharmacy diabetes service model in
australia[J].ClinicalPractice,2007,24(6):677-680.
[15] Kilpatrick E. Response to van de Sande,et al.: The relation?
ship between patient education and glycaemic control in a South
African township, Prim. Care Diabetes1(2) (2007)87-91[J]
.Prim Care Diabetes,2008,2(2):105.
[16]Petkova VB, Petrova GI. Pilot project for education of patients
with type2 diabetes by pharmacists[J].Acta Diabetol,
2006,43(2):37-42.
[17]Choe HM, Bernstein SJ, Mueller BA,et al. Pharmacist leads
primary care team to improve diabetes care[J].Am J Health
SystPharm,2009,66(7):622-624.
[18] Collins C, Limone BL, Scholle JM,et al. Effect of pharmacist
intervention on glycemic control in diabetes[J].Diabetes Res
Clin Pract,2011,92(2):145-152.
[19] Shimizu T, Nathan DM, Buse JB,et al. Medical management
of hyperglycemia in type2diabetes: a consensus algorithm for
the initiation and adjustment of therapy: a consensus statement
of the American Diabetes Association and the European Asso?
ciation for the Study of Diabetes[J].Nihon Rinsho,2012,70
(Suppl3):591-601.
[20]Bailey CJ, Kodack M. Patient adherence to medication require?
ments for therapy of type2diabetes[J].Int J Clin Pract,
2011,65(3):314-322.